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ABST RACT
Starting from a new organic sunscreen synthesized in our laboratory
by the condensation of sodium salt of the p-aminosalicylic acid with
2,6 – dichloroacetanilide, efficient cosmetic formulation with broad
photoprotective properties was obtained by using the new compound
as organic UV filter, metal oxides as inorganic filters, and vegetable
extracts, oils and other ingredients with emollient, protective, and
moisturizing effect. After showing the lack of toxicity of the new
compound, in order to reduce the amount of UV filter used, it was
encapsulated into nanostructured lipid carriers (NLCs). The final
cream has demonstrated good qualities for skin application, possessing
suitable physicochemical characteristics (pH, viscosity) and
spreadability. The SPF value of the product is 16, a value considered
to be satisfactory.

Introduction
Salicylates are water-insoluble, stable, and safe
aromatic compounds used as UVB absorbers [1]. For the
present study we used an organic sunscreen synthesized in
our laboratory by the condensation of sodium salt of the paminosalicylic acid with 2,6 – dichloroacetanilide.
The molecular structure of the obtained compound was
established by IR absorption, as represented in Figure 1.

Figure 1. The molecular structure of the synthesized
esteramide.
A study of acute toxicity was developed in order to
prove the safety of the product. Acute toxicity studies are
designed to determine the dose that will produce either
mortality or serious toxicological effects when given once
or as multiple administrations. These studies provide an
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opportunity to determine the effects the compound on
morphology, clinical chemistry, or other parameters [2].
After demonstrating the structure and the lack of
toxicity of the new compound, it was encapsulated into
nanostructured lipid carriers (NLCs) and we prepared a
dermocosmetic product under a form of a cream. For this,
we have selected, beside the studied esteramide, more
active ingredients (inorganic ﬁlters, natural products,
antioxidants), chosen to ensure a photoprotective and
hydrating effect on the skin. In order to reduce the toxicity
and the amount of UV filter used in cosmetic formulation
[3], the condensation of sodium salt of the p-aminosalicylic
acid with 2,6 – dichloroacetanilide was incorporated into
nanostructured lipid carriers (NLCs).
Sunscreen creams are presenting a triple action: intense
hydration; strong, well-balanced and photostable UVA and
UVB protection [4], and synergistic long-lasting anti-free
radicals’ protection.
These lipid nanostructures are new colloidal delivery
systems developed from oil/ water emulsions type, where
the oil phase was replaced by a mixture of solid and liquid
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lipids. NLCs are submicron particles with spherical shape
and average diameters raging of 40-500 nm that are
generally used for the delivery of lipophilic compounds.
The lipid matrix is formed by physiological lipids that are
not toxic [5].
The sea buckthorn seed oil has a remarkable ability to
nourish, soothe, and protect the skin from sunburns. It
slows the aging process of epidermis by the anti-free
radicals’ effect [6, 7] and by the regeneration of age-altered
connective tissue. It can be successfully used for treating
eczema, rash, and pruritus caused by different skin lesions.
Lately, grapeseed oil is often used on the skin, which it
nourishes, prevents its drying, and helps maintain youth
and natural elasticity. It contains two powerful antioxidant
ingredient called proanthocyanidin and trans-resveratrol,
showing protective effects against UV-induced oxidative
stress, by supporting the functionality of endogenous
antioxidant systems, prevention of the photodegradation of
biological macromolecules (lipids, proteins, DNA), and
inhibition of activation of MAPK (mitogen-activated
protein kinase) and NF-kB (kappa B nuclear factor) cell
signaling pathways [8].
The present study aimed to formulate, prepare, and
subsequently evaluate a sunscreen cream (W/O emulsion)
assessed for organoleptic, functional, physicochemical,
and rheological behavior parameters.

Materials and Methods
The synthesis of esteramide is activated by microwave
action [9]. After 1 minute, only 25% of the reaction took
place, according to the HPLC checking. That is why, in
order to complete it, the reaction time was extended to 6.5
minutes, which is approximately 20 times as short as the
time needed in classical conditions.
The 2,6 – dichloroacetanilide was prepared according
to the reference material. The sodiumaminosalicylate, a
Merck product, was not purified. The obtained compound
was characterized in a previous study [3,9].
Within the electronic spectra there are wide absorption
bands (from 280 to 320 nm) as result of the extended
conjugation of the chromophore on the whole molecule
after condensation of raw materials. The new compound
presents the potential photoprotective action. The
molecular structure of these compounds was established by
UV, IR absorption and 1H-NMR spectra [3,9].
The acute toxicity study:
Animals
Ten healthy male NMRI mice weighing 31.5 ± 3 g
obtained from the “Cantacuzino” Institute, Bucharest,
Romania, were used. The animals were housed in plastic
cages in an air-conditioned animal room and fed on
granulated food with free access to water. The temperature
and relative humidity were continuously monitored using a
thermo-hygrometer ranging between 20-22ºC and
194

respectively 35 - 45%. All procedures were carried out in
accordance with the Directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010 on the
protection of animals used for scientific purposes and the
implementing Law no. 43/2014 on the protection of
animals used for scientific purposes.
Experimental design
The esteramide obtained by condensation of sodium
salt of the p-aminosalicylic acid with 2,6 –
dichloroacetanilide was orally administered to the animals
in the dose of 1000 mg/kg bw, as an 10% aqueous
suspension. The mice were monitored for 14 days for:
lethality, body weight dynamics, social behaviour, and
appearance.
Statistical analyses
Statistical analyses were performed with GraphPad
Prism version 5.00 for Windows, GraphPad Software, San
Diego California USA, www.graphpad.com. Results are
expressed as mean ± standard deviation. The applied t test
has a 90% confidence interval (CI90%). Statistical
significance was considered for p < 0.05.
The preparation method of NLCs was the melt
emulsification method coupled with high shear
homogenization method. The two phases (lipid and
aqueous) were separately heated at 85°C while stirring.
Then, the lipid phase was gradually added over the aqueous
phase. The emulsion was heated under stirring at 85°C for
1 h, and then homogenized by applying 25000 rpm for 10
min (High-shear homogenizer PRO250). To remove the
water, the dispersions were frozen for 24 h and then
lyophilized using a Christ Alpha 1-2 LD Freeze Dryer for
72 h at -55ºC.
Formulation and obtaining the cosmetic preparation
The cream formulation consists in the association
between the active ingredients and the adequate excipients,
chosen in certain amounts, in order to assure the final
product with suitable physicochemical characteristics and
an optimal photoprotective efficiency. The formulation is
shown in Table I.
Ingredients:
- one new organic ﬁltering photoprotective substance
previously obtained according to the reference method
encapsulated in the form of NLCs, in 2% dose;
- two inorganic screen photoprotective substances:
titanium dioxide coated with alumina and silicon (titanium
dioxide M170) and zinc oxide which acts on the entire
UVA and UVB spectrum;
- vegetal oils: grape seed oil (contains important amounts
of vitamins E and F, minerals: zinc, copper, selenium, and
above all, the procyanidins which are antiaging agents 50
times stronger than vitamin E and C), olive oil (consisting
mainly of fatty acids), sea buckthorn seed oil (extracted
from Hippophae rhamnoides seeds, is rich in bioactive
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substances as carotenoids, flavonoids, vitamins A, C, E,
B1, B2, K and PP, as well as microelements, essential fatty
acids and phytosterols);
- vegetal extracts: Chamomile extract (bisabolol and
matricine are wound healing, anti-inflammatory and
antiallergic agents), Rosemary extract (antioxidative,
antimicrobial, anti-inflammatory and anti-aging properties,
inhibits the oxidation of polyunsaturated fatty acids in
membranes),
- natural antioxidants: vitamins A, E, and C;
- natural products having a slight photoprotective, a
hydrating and emollient actions like allantoin and shea
butter [10];
- cyclopentasiloxane and cyclohexasiloxane are siliconbased compounds with emollient and lubricant properties.
After their use, the skin remains soft, with a silky texture,
due to the fact that it forms a seal or barrier on the skin.
This barrier protects against transepidermal water loss.
Usually they are used in combination to assure a better
function as carrying and wetting agents. They have no
known side effects;
- viscosity modifying agents; preservatives, natural
perfumed composition.
The lipid components and zinc oxide were melted
together on a water bath heated at a temperature of about
40-50ºC. The titanium dioxide was dispersed in the
aqueous phase and then heated at a temperature slightly
higher than that of the lipophilic phase, and then they were
gradually brought together while stirring. The obtained
emulsion was cooled to a temperature of 30ºC, a
temperature that allowed the incorporation of the
esteramide, vitamin A, C, E and perfume.
Quality control of the photoprotective product
The organoleptic control (appearance, color, smell,
finesse, adhesion) was performed according to F.R.X
guidelines.
The pH determination was carried out in an aqueous
phase, which was obtained by shaking 1 g of product into
10 ml heated water.
Spreadability on the skin: The determination was
performed using the extensiometric method. This analysis
determines the deformation ability of the product when
several forces are acting on it, by using Ojeda Arbussa
method [11-13].
Viscosity: In order to evaluate the structural
characteristics of the product, we used Thermo Haake
VT550 (ViscoTesterVT550), Thermo Electron (Karlsruhe)
GmbH, Germany, a rheometer with the cylinder assembly
SV – DIN (0 – 100 range of shear speeds, 10 ml volume).
The primary registration and processing of the dates was
done by using Haake RheoWin DataManager, Version
4.30.0011, Thermo Electron (Karlsruhe) GmbH, Germany,
a compatible specialized software.

For analysis of product flowability, the recorded data
has been evaluated by applying the Ostwald de Waele
model [14, 15].
The determination of SPF: In this study, the SPF was
determined in vitro according to the methodology of
Diffey-Robson (16), using an UV- VIS Spectrometer V670
apparatus (Jasco) equipped with integrating sphere and
adequate software. The method is based on measuring the
radiation transmitted by the sample deposited on the
substrate (2 mg/cm2), by recording the photocurrent from
5 to 5 nm on 290-400 nm (UVB, UVA). The cosmetic
preparation was applied to a synthetic skin (Transpore
tape) and subjected to spectrophotometric analysis at six
different points. The average recorded values were used to
calculate the SPF, according to the equation:
SPF =Σ ΕλΒλ / Σ (ΕλΒλ)/ΜPFλ
where Eλ is the spectral irradiance of terrestrial sun light
under deﬁned conditions; Bλ is the erythema effectiveness;
MPFλ is the monochromatic protection factor for each
wavelength increment [3].
Table I. The formulation of the photoprotective product
Ingredients

Quantity (g)

NLCs containing the esteramide obtained
by condensation of sodium salt of the paminosalicylic acid with 2,6 –
dichloroacetanilide

2

Titanium dioxide M170
Zinc oxide
Allantoin
Grapeseed oil
Olive oil
Sea buckthorn seed oil
Chamomile extract
Rosemary extract
Vitamin A
Vitamin C
Vitamin E
Shea butter
Acid stearic
PEG-6 stearate
Glycerin
PEG-12 stearate
Cyclopentasiloxane
Cyclohexasiloxane
Bisabolol
Sodium hydroxide
Butylhydroxyanisole
Perfume
Distilled water

1
1
0.2
2
10
5
1
1
150000 UI
0.5
0.2
10
1.2
7
6.5
4.5
1.2
0.6
0.2
0.05
0.05
q.s.
q.s.
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The results registered in the acute toxicity study are
presented in Figure 2.

The cosmetic formulation showed a homogeneous
appearance, with white to yellowish color and a pleasant
smell. These characteristics remained unchanged during 3
months storage, there being no phase separation or any sort
of precipitation. The formulation presented a pH of 6.3,
immediately after preparation, and remained unchanged
throughout the 90 days of testing.
The plasticity control results are shown in Table II and
Figure 3.

*

* *
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Photoprotective product characteristics

Body weight (g)

40

Observation period

Figure 2. Body weight evolution of the tested animals
(* p < 0.05)

Table II. Variation of spread area with the applied weight
Area (mm2)
Applied weight (g)

Immediately after
preparation

After 30 days

After 60 days

After 90 days

145

725,47

725,47

706,5

687,79

245

1145,5

1133,54

1098,03

1063,08

345

1547,52

1547,52

1519,76

1478,59

645

2238,47

2205,07

2155,42

2090,11

Figure 3. Extensiometric curve of the cosmetic product
The experimental results obtained for the
photoprotective product are presented by variation in shear
tension as a function of shear speed and viscosity (Table III
and Figure 4).
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Figure 4. Variation of viscosity function of shear
tension
The determination of SPF
UV protection factor of the final product was 16, a
value considered to be satisfactory, the product being able
to offer a good protection.
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Table III. Variation of shear tension and viscosity
Parameters

ϓ, 1/s

‚ Pa

, Pas

T, °C

t,s

t_seg s

1|1

1,109

15,51

13,99

27,57

3,281

1,078

1|2

2,045

20,69

10,12

27,58

13,09

10,89

1|3

3,092

24,38

7,884

27,61

23,97

21,77

1|4

4,004

26,97

6,735

27,58

33,81

31,61

1|5

5,027

30,66

6,1

27,59

44,69

42,49

1|6

5,938

33,25

5,599

27,6

54,45

52,25

1|7

6,961

35,46

5,095

27,57

65,34

63,14

1|8

7,996

38,42

4,805

27,57

75,19

72,99

1|9

9,031

41,74

4,622

27,58

86,05

83,84

1|10

10,07

45,07

4,477

27,57

96,95

94,75

1|11

10,96

46,54

4,245

27,55

106,7

104,5

1|12

12

50,61

4,217

27,56

117,7

115,5

1|13

13,03

52,09

3,996

27,55

127,5

125,3

1|14

14,06

53,56

3,81

27,54

138,4

136,2

1|15

14,97

55,78

3,726

27,52

148,3

146,1

1|16

16

58

3,624

27,51

159,2

157

1|17

16,9

60,21

3,562

27,53

169

166,8

1|18

18,06

63,17

3,497

27,52

179,8

177,6

1|19

19,1

64,65

3,385

27,54

190,8

188,6

1|20

20

65,38

3,27

27,53

200,6

198,4

1|21

21,03

67,6

3,214

27,52

211,5

209,3

1|22

21,93

67,6

3,083

27,5

221,3

219,1

1|23

23,09

69,45

3,008

27,47

232,3

230,1

1|24

24

69,82

2,909

27,48

242,1

239,9

1|25

24,9

68,34

2,745

27,46

253

250,8

2|1

24,9

67,97

2,73

27,48

259,5

5,078

2|2

24,9

69,45

2,789

27,47

264,4

10,01

3|1

24,9

67,97

2,73

27,47

268

1,093

3|2

23,86

67,23

2,817

27,46

277,8

10,92

3|3

22,96

66,86

2,912

27,48

287,7

20,84

3|4

21,93

66,12

3,015

27,48

298,7

31,8

3|5

20,89

65,38

3,129

27,48

309,6

42,69
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3|6

19,87

65,75

3,309

27,45

319,4

52,47

3|7

18,84

64,65

3,432

27,45

330,2

63,36

3|8

17,94

63,17

3,521

27,42

340,1

73,22

3|9

16,9

61,69

3,65

27,44

351

84,09

3|10

15,87

60,95

3,841

27,45

360,8

93,91

3|11

14,83

60,21

4,059

27,45

371,7

104,8

3|12

13,93

58,73

4,215

27,45

381,5

114,6

3|13

12,9

57,63

4,467

27,46

392,4

125,5

3|14

11,86

56,52

4,764

27,41

403,3

136,5

3|15

10,84

55,04

5,077

27,44

413,2

146,3

3|16

9,807

52,45

5,349

27,42

424,1

157,2

3|17

8,907

50,61

5,682

27,42

433,9

167

3|18

7,872

48,39

6,147

27,38

444,8

177,9

3|19

6,961

45,81

6,581

27,42

454,6

187,7

3|20

5,938

42,48

7,154

27,43

465,5

198,6

3|21

4,903

39,53

8,061

27,42

475,3

208,4

3|22

3,868

34,72

8,976

27,39

486,2

219,3

3|23

2,834

29,55

10,43

27,4

497,1

230,2

3|24

1,971

24,38

12,37

27,4

506,9

240

3|25

0,998

16,25

16,29

27,39

517,8

250,9

Discussions
After the animal’s exposure to the studied compound,
in the dose of 1000 mg/kg bw, no lethal effect was
registered. During the observation period no signs of
alterations related to social behavior or appearance were
noted. The mice body weight showed a positive trend
during the observation period, with statistical significance
by the end of the experiment (Figure 2).
The pH values obtained after preparation and during the
90 days of testing show that the product is compatible with
the skin pH and does not causes skin irritation when
applied [17].
Regarding the spreading characteristics, the surface of
display increases with increasing the added weights,
showing good plasticity which is maintained during the
storage time of 90 days. The formulation has very good
spreadability [18,19].
The flowability is an essential element both for the
purpose of ensuring compliance, but also to ensure a
controlled deformation after administration, favorable for
drug release.
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The coefficients of correlation between experimental
and estimated data, according to the model, present values
higher than 0.999. We note the sub-unit values of the flow
indices, which confirm the pseudoplastic character of the
product [17,20].
The dichloroacetanilide, and also to the other
ingredients used in the formulation (titanium dioxide, zinc
oxide, grapeseed, sea buckthorn seed oil and olive oil),
leading to the conclusion that the selected ingredients had
a synergic mechanism of action [18-21].

Conclusions
The present study started with the synthesis process of
a photoprotective product by condensation of sodium salt
of the p-aminosalicylic acid with 2,6 – dichloroacetanilide.
After establishing its molecular structure, a test for acute
toxicity was conducted. At the end of the observation
period, no changes in the term of lethality, motor behavior,
aggressivity, or aspect (fur, mucus) were registered. The
product was encapsulated into nanostructured lipid carriers
(NLCs) in order to reduce the amount of UV filter used in
cream formulation.

Formulation and characterization of a photoprotective cream containing a new compound

Starting from the lyophilized esteramide-lipid
nanostructures, efficient cosmetic formulation with broad
photoprotective properties was obtained by using the new
compound as organic UV filter, metal oxides as inorganic
filters, and vegetable extracts, oils and other ingredients
with emollient, protective, and moisturizing effects. The
obtained cosmetic product has proven qualities for skin
application,
possessing
suitable
physicochemical
characteristics (pH, viscosity) and spreadability.
Regarding the cream’s flow behavior, the rheological
profile showed it is fluid enough to flow easily, but also
will not drip and remains on the application site in the
presence of a mechanical stress, inevitable and
characteristic for the administration of a topical semi-solid
product. The flowability significantly affects the amount of
ingredients transferred to the target area of the human
body.
The studied product has a pseudoplastic flow behavior,
this being confirmed by applying the Ostwald de Waele
method.
The SPF value of the product is 16, the final
pharmaceutical form showing an adequate protection of the
skin from sunburn.
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